Photo from wikipedia
HK Reddel, WW Busse, S Pedersen. Lancet. 2017;389(10065):157–166 The 3-year Steroid Treatment as Regular Therapy (START) study evaluated the symptom-based cutoff of >2 days per week for starting daily inhaled… Click to show full abstract
HK Reddel, WW Busse, S Pedersen. Lancet. 2017;389(10065):157–166 The 3-year Steroid Treatment as Regular Therapy (START) study evaluated the symptom-based cutoff of >2 days per week for starting daily inhaled steroid therapy for management of mild asthma. Participants ( N = 7138, ages 4–66 years) were from 32 countries, had mild asthma diagnosed within the past 2 years, and no previous regular corticosteroid therapy. This post-hoc analysis of a randomized control trial comparing once-daily inhaled …
Keywords:
start study;
mild asthma;
treatment;
post hoc
Journal Title: Pediatrics
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Pediatrics
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!